MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $669,000 | +31.2% | 11,096 | 0.0% | 0.02% | +29.4% |
| Q1 2016 | $510,000 | -4.9% | 11,096 | 0.0% | 0.02% | -10.5% |
| Q4 2015 | $536,000 | +13.6% | 11,096 | 0.0% | 0.02% | +26.7% |
| Q3 2015 | $472,000 | -25.6% | 11,096 | +100.0% | 0.02% | -25.0% |
| Q2 2015 | $634,000 | +46.8% | 5,548 | +65.7% | 0.02% | +53.8% |
| Q1 2015 | $432,000 | +29.7% | 3,348 | 0.0% | 0.01% | +30.0% |
| Q4 2014 | $333,000 | -94.1% | 3,348 | -96.5% | 0.01% | -95.4% |
| Q3 2013 | $5,658,000 | – | 94,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |